R&D platform company for
multiple pharma cannabis indications
Cannamore is a 'Clinical & Pre-Clinical Stage' research company. Committed to the research & development of novel and improved 'Cannabis-Based Solutions'
Strategic partnership with – Mor Research Applications
The TTO company of Clalit Health Services – the largest HMO in Israel
CannaMore’s ability to conduct simultaneous research and development of different indications and solutions allows various ‘EXIT’ strategies both for it’s subsidiaries while allowing a possible IPO for CannaMore itself